中商官网
研究报告
振德医疗（603301）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2014 | 987000000.0000 | 16323000.0000 | 24297700.0000 | 21986600.0000 | 1110000000.0000 | 1004000000.0000 | 106000000.0000 |
| 2015 | 1021000000.0000 | 82491400.0000 | 91296400.0000 | 79249400.0000 | 1275000000.0000 | 1012000000.0000 | 262000000.0000 |
| 2016 | 1035000000.0000 | 79174500.0000 | 99634500.0000 | 82882600.0000 | 1128000000.0000 | 690000000.0000 | 438000000.0000 |
| 2017 | 1306000000.0000 | 148000000.0000 | 147000000.0000 | 122000000.0000 | 1294000000.0000 | 734000000.0000 | 560000000.0000 |
| 2018 | 1429000000.0000 | 153000000.0000 | 152000000.0000 | 130000000.0000 | 1850000000.0000 | 725000000.0000 | 1125000000.0000 |
| 2019 | 1868000000.0000 | 200000000.0000 | 199000000.0000 | 177000000.0000 | 2669000000.0000 | 1270000000.0000 | 1400000000.0000 |
| 2020 | 10399000000.0000 | 3537000000.0000 | 3533000000.0000 | 2972000000.0000 | 6400000000.0000 | 1933000000.0000 | 4467000000.0000 |
| 2021 | 5092000000.0000 | 822000000.0000 | 820000000.0000 | 721000000.0000 | 6422000000.0000 | 1982000000.0000 | 4440000000.0000 |
| 2022 | 6138000000.0000 | 813000000.0000 | 802000000.0000 | 702000000.0000 | 7896000000.0000 | 2140000000.0000 | 5756000000.0000 |
| 2023 | 4127000000.0000 | 226000000.0000 | 219000000.0000 | 213000000.0000 | 7267000000.0000 | 1662000000.0000 | 5604000000.0000 |
| 2024 | 4264000000.0000 | 492000000.0000 | 475000000.0000 | 397000000.0000 | 7577000000.0000 | 1680000000.0000 | 5896000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2014 | 1.93 | 2.46 | 2.19 | 13.4300 | 4.5700 | 5.67 | 0.89 |
| 2015 | 6.27 | 8.94 | 7.16 | 50.9200 | 4.5500 | 5.89 | 0.80 |
| 2016 | 7.05 | 9.63 | 8.83 | 21.8800 | 3.9500 | 5.91 | 0.92 |
| 2017 | 8.35 | 11.26 | 11.36 | 24.4300 | 4.3900 | 7.12 | 1.01 |
| 2018 | 7.70 | 10.64 | 8.22 | 14.2500 | 3.3600 | 6.26 | 0.77 |
| 2019 | 7.49 | 10.65 | 7.46 | 13.2800 | 3.1400 | 5.84 | 0.70 |
| 2020 | 33.60 | 33.97 | 55.20 | 94.8800 | 7.3000 | 20.07 | 1.62 |
| 2021 | 13.71 | 16.10 | 12.77 | 14.2200 | 3.4700 | 7.52 | 0.79 |
| 2022 | 13.15 | 13.07 | 10.16 | 14.8400 | 4.5300 | 8.42 | 0.78 |
| 2023 | 4.29 | 5.31 | 3.01 | 3.6000 | 3.1100 | 6.31 | 0.57 |
| 2024 | 8.21 | 11.14 | 6.27 | 7.0000 | 3.5800 | 6.58 | 0.56 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2014 | 90.45 | 9.55 | 0.6100 | 0.4000 |
| 2015 | 79.37 | 20.55 | 0.7500 | 0.4200 |
| 2016 | 61.17 | 38.83 | 0.8100 | 0.4100 |
| 2017 | 56.72 | 43.28 | 0.8700 | 0.4700 |
| 2018 | 39.19 | 60.81 | 1.5200 | 0.8700 |
| 2019 | 47.58 | 52.45 | 2.0000 | 1.3500 |
| 2020 | 30.20 | 69.80 | 2.5000 | 1.5800 |
| 2021 | 30.86 | 69.14 | 1.9900 | 1.3100 |
| 2022 | 27.10 | 72.90 | 2.7200 | 1.9800 |
| 2023 | 22.87 | 77.12 | 2.3200 | 1.5400 |
| 2024 | 22.17 | 77.81 | 2.2800 | 1.5000 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2014 | 968000000.0000 | 45045400.0000 | 102000000.0000 | 44172700.0000 |
| 2015 | 957000000.0000 | 68839800.0000 | 130000000.0000 | 28797800.0000 |
| 2016 | 962000000.0000 | 77430100.0000 | 137000000.0000 | 17013900.0000 |
| 2017 | 1197000000.0000 | 89318700.0000 | 101000000.0000 | 29632100.0000 |
| 2018 | 1319000000.0000 | 118000000.0000 | 111000000.0000 | 23772300.0000 |
| 2019 | 1728000000.0000 | 188000000.0000 | 169000000.0000 | 25089300.0000 |
| 2020 | 6905000000.0000 | 492000000.0000 | 386000000.0000 | 113000000.0000 |
| 2021 | 4394000000.0000 | 367000000.0000 | 442000000.0000 | 39104900.0000 |
| 2022 | 5331000000.0000 | 477000000.0000 | 507000000.0000 | 11648900.0000 |
| 2023 | 3950000000.0000 | 381000000.0000 | 513000000.0000 | 17171900.0000 |
| 2024 | 3914000000.0000 | 369000000.0000 | 522000000.0000 | 4429600.0000 |